会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 62. 发明授权
    • Vaccine against Neisseria meningitidis infections
    • 疫苗针对脑膜炎奈瑟菌感染
    • US5618541A
    • 1997-04-08
    • US66167
    • 1993-06-02
    • Marie-Jose Quentin-Millet
    • Marie-Jose Quentin-Millet
    • A61K39/095A61K38/00A61P31/04C07K1/22C07K14/195C07K14/22C07K14/41C07K14/705C12P21/02C12R1/36A61K31/075
    • C07K14/22A61K38/00Y10S435/871
    • A vaccinal pharmaceutical composition which comprises, as therapeutic agents, at least a first and a second molecule capable of binding to human transferrin; the said first molecule originating from a first strain of N. meningitidis which possesses a human transferrin receptor in which the lower molecular weight subunit (Tbp2) is recognised by an antiserum to the receptor of N. meningitidis strain 2394 (receptor 2394) and is not recognised by an antiserum to the receptor of N. meningitidis strain 2169 (receptor 2169); and at least a second molecule originating from a second strain of N. meningitidis which possesses a human transferrin receptor in which the lower molecular weight subunit (Tbp2) is recognised by an anti-receptor 2169 antiserum and is not recognised by an anti-receptor 2394 antiserum.
    • PCT No.PCT / FR92 / 00905 Sec。 371日期:1993年6月2日 102(e)日期1993年6月2日PCT提交1992年9月29日PCT公布。 出版物WO93 / 06861 日期:1993年04月15日一种疫苗药物组合物,其包含至少一种能够结合人转铁蛋白的第一和第二分子作为治疗剂; 所述第一分子源自具有人类转铁蛋白受体的脑膜炎奈瑟氏球菌的第一菌株,其中低分子量亚基(Tbp2)被脑膜炎奈瑟氏球菌菌株2394(受体2394)的受体的抗血清识别,并且不是 被脑膜炎奈瑟氏球菌菌株2169(受体2169)的受体的抗血清识别; 和至少一种源自第二脑膜炎奈瑟氏球菌菌株的第二分子,其具有人类转铁蛋白受体,其中低分子量亚基(Tbp2)被抗受体2169抗血清识别,并且不被抗受体2394识别 抗血清
    • 63. 发明授权
    • Method for detecting Branhamella catarrhalis
    • 用于检测粘膜炎白念珠菌的方法
    • US5556755A
    • 1996-09-17
    • US129719
    • 1993-09-29
    • Timothy F. Murphy
    • Timothy F. Murphy
    • A61K38/00A61K39/00C07K14/21C12Q1/68C07H21/04C12N15/00C12P19/34
    • C07K14/212A61K38/00A61K39/00Y10S435/871
    • Compositions comprising outer membrane protein "CD", and peptides thereof, of Branhamella catarrhalis are described. Additionally, nucleotide sequences encoding the protein or peptide are disclosed, as well as recombinant vectors containing these sequences. Protein or peptide can be produced from host cell systems containing these recombinant vectors. Peptides can also be chemically synthesized. Disclosed are the uses of the protein and peptides as antigens for vaccine formulations, and as antigens in diagnostic immunoassays. The nucleotide sequences are useful for inserting into a viral vector in constructing a recombinant viral vaccine. Also described is the use of nucleotide sequences related to the gene encoding CD as primers and/or probes in molecular diagnostic assays for the detection of B. catarrhalis.
    • 描述了包含布列塔门氏菌属的外膜蛋白“CD”及其肽的组合物。 此外,公开了编码蛋白质或肽的核苷酸序列,以及含有这些序列的重组载体。 可以从含有这些重组载体的宿主细胞系统产生蛋白质或肽。 肽也可以化学合成。 公开了蛋白质和肽作为疫苗制剂的抗原以及作为诊断性免疫测定中的抗原的用途。 核苷酸序列可用于在构建重组病毒疫苗中插入病毒载体。 还描述了在分子诊断测定中使用与编码CD的基因作为引物和/或探针相关的核苷酸序列用于检测卡他莫拉菌。
    • 64. 发明授权
    • Support-bound nucletide probe for neisseria gonorrhoeae
    • 淋病奈瑟氏球菌支架结合核苷酸探针+ B
    • US5525717A
    • 1996-06-11
    • US83946
    • 1993-06-25
    • Charles G. MiyadaTeresa L. Born
    • Charles G. MiyadaTeresa L. Born
    • C07K7/06C07K16/12C12N15/31C12Q1/68C07H21/00C12P19/34
    • C12Q1/689Y10S435/822Y10S435/871
    • A nucleotide sequence characteristic of Neisseria gonorrhoeae is disclosed. The sequence can be the basis for hybridization type, nucleic acid-based, rapid, in vitro diagnostic assays. The unique nature of the sequence makes it possible to clearly discriminate N. gonorrhoeae from other Neisseria species thus eliminating or substantially reducing the number of false positive readings. A 350 base pair N. gonorrhoeae DNA restriction fragment was cloned after subtractive hybridization to Neisseria meningitidis DNA. In further cloning experiments the sequences adjacent to the original 350 base pair fragment were determined. A portion of this sequence was shown to detect 105 of 106 N. gonorrhoeae strains and no other Neisseria species. In addition to use as detection probes, all or portions of the nucleotide sequence can be used as a ligand for the sandwich capture of N. gonorrhoeae sequences and as primers for in vitro amplification of N. gonorrhoeae sequences. The polypeptides encoded by the presently disclosed sequence, including antibodies thereto, are also disclosed as are their uses.
    • 披露了淋病奈瑟氏球菌特征的核苷酸序列。 该序列可以是杂交类型,基于核酸,快速,体外诊断测定的基础。 序列的独特性质使得可以清楚地区分淋病奈瑟氏球菌与其他奈瑟氏菌属物种,从而消除或显着减少假阳性读数的数量。 在与奈瑟氏球菌脑膜炎奈瑟菌DNA消减杂交后克隆了350碱基对淋病奈瑟氏球菌DNA限制性片段。 在进一步克隆实验中,确定与原始350碱基对片段相邻的序列。 该序列的一部分显示检测到106个淋病奈瑟氏球菌菌株中的105个,并且没有其他的奈瑟球菌属物种。 除了用作检测探针之外,核苷酸序列的全部或部分可以用作奈氏淋病奈瑟氏球菌序列的夹心捕获的配体,并且用作用于体外扩增淋病奈瑟氏球菌序列的引物。 本文公开的序列编码的多肽(包括其抗体)也被用于其用途。
    • 65. 发明授权
    • Colorimetric method for beta-lactamase assay and its applications
    • β-内酰胺酶测定法比色法及其应用
    • US5264346A
    • 1993-11-23
    • US710510
    • 1991-06-03
    • Kirk C. S. Chen
    • Kirk C. S. Chen
    • G01N31/22C12Q1/26C12Q1/28
    • G01N31/22Y10S435/871Y10S435/933Y10S435/973Y10S436/904
    • A novel colorimetric method for beta-lactamase assay and its applications are disclosed. The novel assay method for beta-lactamase is based on the discovery described in this invention. The chromophore formed by oxidation of either the N-alkyl derivative of p-phenylenediamine or the 3,3',5,5'-tetraalkyl derivative of benzidine can be decolorized by the open beta-lactam ring end product resulting from the hydrolysis of a penicillin in the presence of a mercury-containing compound. The same chromophore can be decolorized by the open beta-lactam ring end product resulting from the hydrolysis of a cephalosporin in either the presence or the absence of the mercury-containing compound. None of the intact beta-lactam antibiotics can decolorize the chromophore in either the presence or the absence of the mercury-containing compound. The final concentration of the mercury-containing compound in the decolorization mixture ranges from approximately 0.005 mM to approximately 3 mM, and the pH of the decolorization mixture ranges from 3.5 to 8.0. Additional applications derived from coupling this novel assay method to methods in the art include: a method for specific detection of microbial beta-lactamases; a method for simultaneous detection of microbial cytochrome c oxidase systems and penicillinases, and its application to simultaneous presumptive identification of Neisseria gonorrhoeae in urethral exudates, and differentiation of the infecting gonococci into penicillinase-producing N. gonorrhoeae and non-penicillinase-producing N. gonorrhoeae; and a simultaneous assay method for peroxidase and penicillinase.
    • 公开了一种β-内酰胺酶测定法的新型比色法及其应用。 β-内酰胺酶的新型测定方法是基于本发明所述的发现。 通过对苯二胺的N-烷基衍生物或联苯胺的3,3',5,5'-四烷基衍生物的氧化形成的发色团可以由开水的β-内酰胺环末端产物脱色 青霉素在含汞化合物存在下。 相同的发色团可以通过在含汞化合物的存在或不存在下由头孢菌素水解产生的开放的β-内酰胺环末端产物脱色。 没有一种完整的β-内酰胺抗生素可以在存在或不存在含汞化合物的情况下使发色团脱色。 脱色混合物中含汞化合物的最终浓度为约0.005mM至约3mM,脱色混合物的pH为3.5至8.0。 将该新型测定方法与本领域的方法联用得到的其它应用包括:用于特异性检测微生物β-内酰胺酶的方法; 同时检测微生物细胞色素c氧化酶系统和青霉素酶的方法,以及其在尿道渗出液中同时推测淋病奈瑟氏球菌的鉴定,以及感染性淋球菌分泌为产青青霉素酶的淋病奈瑟氏球菌和产生非青霉素酶的淋病奈瑟氏球菌 ; 以及过氧化物酶和青霉素酶的同时测定方法。
    • 66. 发明授权
    • Nucleotide probe for Neisseria gonrrhoeae
    • 奈瑟氏球菌的核苷酸探针
    • US5256536A
    • 1993-10-26
    • US611528
    • 1990-11-09
    • Charles G. MiyadaTeresa L. Born
    • Charles G. MiyadaTeresa L. Born
    • C07K7/06C07K16/12C12N15/31C12Q1/68C12G1/68C07M15/12C12D12/34C12Q1/10
    • C12Q1/689Y10S435/822Y10S435/871
    • A nucleotide sequence characteristic of Neisseria gonorrhoeae is disclosed. The sequence can be the basis for hybridization type, nucleic acid-based, rapid, in vitro diagnostic assays. The unique nature of the sequence makes it possible to clearly discriminate N. gonorrhoeae from other Neisseria species thus eliminating or substantially reducing the number of false positive readings. A 350 base pair N. gonorrhoeae DNA restriction fragment was cloned after subtractive hybridization to Neisseria meningitidis DNA. In further cloning experiments the sequences adjacent to the original 350 base pair fragment were determined. A portion of this sequence was shown to detect 105 of 106 N. gonorrhoeae strains and no other Neisseria species. In addition to use as detection probes, all or portions of the nucleotide sequence can be used as a ligand for the sandwich capture of N. gonorrhoeae sequences and as primers for in vitro amplification of N. gonorrhoeae sequences. The polypeptides encoded by the presently disclosed sequence, including antibodies thereto, are also disclosed as are their uses.
    • 披露了淋病奈瑟氏球菌特征的核苷酸序列。 该序列可以是杂交类型,基于核酸,快速,体外诊断测定的基础。 序列的独特性质使得可以清楚地区分淋病奈瑟氏球菌与其他奈瑟氏菌属物种,从而消除或显着减少假阳性读数的数量。 在与奈瑟氏球菌脑膜炎奈瑟菌DNA消减杂交后克隆了350碱基对淋病奈瑟氏球菌DNA限制性片段。 在进一步克隆实验中,确定与原始350碱基对片段相邻的序列。 该序列的一部分显示检测到106个淋病奈瑟氏球菌菌株中的105个,并且没有其他的奈瑟球菌属物种。 除了用作检测探针之外,核苷酸序列的全部或部分可以用作奈氏淋病奈瑟氏球菌序列的夹心捕获的配体,并且用作用于体外扩增淋病奈瑟氏球菌序列的引物。 本文公开的序列编码的多肽(包括其抗体)也被用于其用途。